NA Vagus Nerve Stimulation Market - Industry Trends and Forecast to 2029
- Published Date: 2022-12-22
- Report ID: 143054
- Pages: 225
-
Format:
Short Description
North America Vagus Nerve Stimulation Market, By Product Type (Implantable VNS Devices and External VNS Devices), Biomaterial (Ceramics, Metallic, and Polymerics), Application (Pain Management, Epileptic Seizures, Obesity Management, Depression and Anxiety, and Others), Patient Type (Adults, Pediatric, and Geriatric), End User (Hospitals, Ambulatory Surgical Centers, Specialty Centers, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others), Country (U.S., Canada, and Mexico) Industry Trends and Forecast to 2029
Market Definition
The vagus nerve is a long cranial nerve that runs from a persons brain stem into the neck, chest, and abdomen. It is a part of the parasympathetic nervous system, which is commonly referred to as the rest-and-digest system because it regulates bodily functions while a person is at rest. It delivers messages to a persons brain from their digestive system and organs such as their lungs, heart, and liver. It controls several organ functions, including digestion, heart rate, and respiratory rate. It is responsible for vasomotor activity and reflexes. It also regulates vocalization, mood, and immunity. It influences sensory functions in a persons ears, sinuses, and esophagus as well.
Vagus Nerve Stimulation (VNS) involves a pulse generator inserted under a persons skin on their chest. The implantable device, which is similar to a pacemaker, delivers regular electrical pulses to the brain via the vagus nerve. It is possible to provide additional stimulation by placing the provided magnet over the pulse generator. Relaxation techniques such as breathing exercises, yoga, and medication can influence vagus nerve activity, increasing its ability to relieve anxiety and mood-related symptoms. VNS can improve an individuals physical health and can offer benefits for several conditions such as epilepsy and depression. The treatment has a healing effect on a persons body due to its ability to promote relaxation and reduce inflammation.
Market Segmentation
North America vagus nerve stimulation market is categorized into six notable segments based on product type, biomaterial, application, patient type, end user, and distribution channel.
Based on product type, the market is segmented into implantable VNS devices and external VNS devices
Based on biomaterial, the market is segmented into ceramics, metallic, and polymerics
Based on application, the market is segmented into pain management, epileptic seizures, obesity management, depression and anxiety, and others
Based on patient type, the market is segmented into adults, pediatrics, and geriatrics
Based on end user, the market is segmented into hospitals, ambulatory surgical centers, specialty clinics, and others
Based on distribution channel, the market is segmented into direct tender, retail sales, and others
Market Players
Some of the key market players in the North America vagus nerve stimulation market are listed below:
electroCore, Inc.
LivaNova PLC
Medtronic
SetPoint Medical
tVNS Technologies GmbH
MicroTransponder Inc.
Others
TABLE OF CONTENTS
1 INTRODUCTION 40
1.1 OBJECTIVES OF THE STUDY 40
1.2 MARKET DEFINITION 40
1.3 OVERVIEW OF NORTH AMERICA VAGUS NERVE STIMULATION MARKET 40
1.4 LIMITATIONS 42
1.5 MARKETS COVERED 42
2 MARKET SEGMENTATION 44
2.1 MARKETS COVERED 44
2.2 GEOGRAPHICAL SCOPE 45
2.3 YEARS CONSIDERED FOR THE STUDY 46
2.4 CURRENCY AND PRICING 46
2.5 DBMR TRIPOD DATA VALIDATION MODEL 47
2.6 MULTIVARIATE MODELLING 50
2.7 LIFELINE CURVE , BY PRODUCT TYPE 50
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 51
2.9 DBMR MARKET POSITION GRID 52
2.10 MARKET APPLICATION COVERAGE GRID 53
2.11 VENDOR SHARE ANALYSIS 54
2.12 SECONDARY SOURCES 55
2.13 ASSUMPTIONS 55
3 EXECUTIVE SUMMARY 56
4 PREMIUM INSIGHTS 59
4.1 PORTERS FIVE FORCES 60
4.2 PESTEL ANALYSIS 61
4.3 KEY STRATEGIC INITIATIVES 62
5 REGULATIONS OF NORTH AMERICA VAGUS NERVE STIMULATION MARKET 63
6 MARKET OVERVIEW 67
6.1 DRIVERS 69
6.1.1 INCREASING PREVALENCE AND INCIDENCE OF NEUROLOGICAL DISORDERS 69
6.1.2 INNOVATIVE NON-INVASIVE VAGUS NERVE STIMULATION DEVICES INTRODUCED TO MEET DEMAND 70
6.1.3 RISE IN PRODUCT APPROVALS 70
6.1.4 PRODUCT DEVELOPMENT IN RECENT YEARS 71
6.2 RESTRAINTS 71
6.2.1 HIGH MAINTENANCE AND DEVICE COSTS TO RESTRAIN ADOPTION OF VAGUS NERVE STIMULATORS 71
6.2.2 RISE IN PRODUCT RECALL 72
6.2.3 UNFAVORABLE REIMBURSEMENT POLICIES 72
6.3 OPPORTUNITIES 73
6.3.1 STRATEGIC INITIATIVES BY KEY MARKET PLAYERS 73
6.3.2 RISING GOVERNMENT INITIATIVES FOR NEUROLOGICAL DISEASE 73
6.4 CHALLENGES 74
6.4.1 RISKS ASSOCIATED WITH THE IMPLANTATION OF THESE DEVICES 74
6.4.2 LACK OF SKILLED HEALTHCARE PROFESSIONALS 74
6.4.3 STRINGENT REGULATIONS FOR APPROVAL OF MEDICAL DEVICES 75
7 NORTH AMERICA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE 76
7.1 OVERVIEW 77
7.2 IMPLANTABLE VNS DEVICE 80
7.3 EXTERNAL VNS DEVICE 80
8 NORTH AMERICA VAGUS NERVE STIMULATION MARKET, BY BIOMATERIAL 81
8.1 OVERVIEW 82
8.2 METALLIC 85
8.3 POLYMERIC 85
8.4 CERAMICS 86
9 NORTH AMERICA VAGUS NERVE STIMULATION MARKET, BY APPLICATION 87
9.1 OVERVIEW 88
9.2 EPILEPTIC SEIZURES 91
9.2.1 IMPLANTABLE VNS DEVICE 91
9.2.2 EXTERNAL VNS DEVICE 91
9.3 DEPRESSION AND ANXIETY 91
9.3.1 IMPLANTABLE VNS DEVICE 92
9.3.2 EXTERNAL VNS DEVICE 92
9.4 PAIN MANAGEMENT 93
9.4.1 IMPLANTABLE VNS DEVICE 93
9.4.2 EXTERNAL VNS DEVICE 93
9.5 OBESITY MANAGEMENT 94
9.5.1 IMPLANTABLE VNS DEVICE 94
9.5.2 EXTERNAL VNS DEVICE 94
9.6 OTHERS 95
10 NORTH AMERICA VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE 96
10.1 OVERVIEW 97
10.2 ADULTS 100
10.2.1 IMPLANTABLE VNS DEVICES 100
10.2.2 EXTERNAL VNS DEVICES 100
10.3 GERIATRIC 101
10.3.1 IMPLANTABLE VNS DEVICES 101
10.3.2 EXTERNAL VNS DEVICES 101
10.4 PEDIATRIC 102
10.4.1 IMPLANTABLE VNS DEVICES 102
10.4.2 EXTERNAL VNS DEVICES 102
11 NORTH AMERICA VAGUS NERVE STIMULATION MARKET, BY END USER 103
11.1 OVERVIEW 104
11.2 SPECIALTY CENTERS 107
11.3 HOSPITALS 107
11.4 AMBULATORY SURGICAL CENTERS (ASCS) 108
11.5 OTHERS 108
12 NORTH AMERICA VAGUS NERVE STIMULATION MARKET, BY DISTRIBUTION CHANNEL 109
12.1 OVERVIEW 110
12.2 DIRECT TENDER 113
12.3 RETAIL SALES 113
12.4 OTHERS 114
13 NORTH AMERICA VAGUS NERVE STIMULATION MARKET, BY REGION 115
13.1 NORTH AMERICA 116
13.1.1 U.S. 124
13.1.2 CANADA 128
13.1.3 MEXICO 132
14 NORTH AMERICA VAGUS NERVE STIMULATION MARKET: COMPANY LANDSCAPE 136
14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 136
15 SWOT ANALYSIS 137
16 COMPANY PROFILE 138
16.1 ELECTROCORE, INC. 138
16.1.1 COMPANY SNAPSHOT 138
16.1.2 REVENUE ANALYSIS 138
16.1.3 COMPANY SHARE ANALYSIS 139
16.1.4 PRODUCT PORTFOLIO 139
16.1.5 RECENT DEVELOPMENTS 139
16.2 LIVANOVA PLC 141
16.2.1 COMPANY SNAPSHOT 141
16.2.2 REVENUE ANALYSIS 141
16.2.3 COMPANY SHARE ANALYSIS 142
16.2.4 PRODUCT PORTFOLIO 142
16.2.5 RECENT DEVELOPMENTS 142
16.3 MEDTRONIC 144
16.3.1 COMPANY SNAPSHOT 144
16.3.2 REVENUE ANALYSIS 144
16.3.3 COMPANY SHARE ANALYSIS 145
16.3.4 PRODUCT PORTFOLIO 145
16.3.5 RECENT DEVELOPMENTS 145
16.4 SETPOINT MEDICAL 146
16.4.1 COMPANY SNAPSHOT 146
16.4.2 COMPANY SHARE ANALYSIS 146
16.4.3 PRODUCT PORTFOLIO 147
16.4.4 RECENT DEVELOPMENTS 147
16.5 TVNS TECHNOLOGIES GMBH 148
16.5.1 COMPANY SNAPSHOT 148
16.5.2 COMPANY SHARE ANALYSIS 148
16.5.3 PRODUCT PORTFOLIO 149
16.5.4 RECENT DEVELOPMENT 149
16.6 NEUROPIX COMPANY LTD. 150
16.6.1 COMPANY SNAPSHOT 150
16.6.2 PRODUCT PORTFOLIO 150
16.6.3 RECENT DEVELOPMENT 150
16.7 BRAIN CONTROL CO. LTD 151
16.7.1 COMPANY SNAPSHOT 151
16.7.2 PRODUCT PORTFOLIO 151
16.7.3 RECENT DEVELOPMENTS 151
16.8 CIRTEC 152
16.8.1 COMPANY SNAPSHOT 152
16.8.2 PRODUCT PORTFOLIO 152
16.8.3 RECENT DEVELOPMENTS 152
16.9 MICROTRANSPONDER INC. 153
16.9.1 COMPANY SNAPSHOT 153
16.9.2 PRODUCT PORTFOLIO 153
16.9.3 RECENT DEVELOPMENT 153
16.10 PARASYM LTD 154
16.10.1 COMPANY SNAPSHOT 154
16.10.2 PRODUCT PORTFOLIO 154
16.10.3 RECENT DEVELOPMENT 154
16.11 RESHAPE LIFESCIENCES INC. (2021) 155
16.11.1 COMPANY SNAPSHOT 155
16.11.2 REVENUE ANALYSIS 155
16.11.3 PRODUCT PORTFOLIO 156
16.11.4 RECENT DEVELOPMENT 156
16.12 SOTERIX MEDICAL INC. 157
16.12.1 COMPANY SNAPSHOT 157
16.12.2 PRODUCT PORTFOLIO 157
16.12.3 RECENT DEVELOPMENTS 157
17 QUESTIONNAIRE 158
18 RELATED REPORTS 161
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
